Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bowes

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Pharmacogenetics and Genomics|March 20, 2010
Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment responseCatherine Potter, Laura J Gibbons, John D Bowes, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Brachytherapy|February 6, 2018
A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recoveryM A Korzeniowski, J M Crook, D Bowes, et al.
Biotechnology Progress|September 25, 2023
Intramodule pressure profiles and protein accumulation during tangential flow filtrationFernanda Cunha, Jessica Zuponcic, Francesco Rossi, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Pharmacogenetics and Genomics|March 20, 2010
Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment responseCatherine Potter, Laura J Gibbons, John D Bowes, et al.
Pharmacogenetics and Genomics|March 6, 2009
Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patientsJohn D Bowes, Catherine Potter, Laura J Gibbons, et al.
Brachytherapy|February 6, 2018
A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recoveryM A Korzeniowski, J M Crook, D Bowes, et al.
Biotechnology Progress|September 25, 2023
Intramodule pressure profiles and protein accumulation during tangential flow filtrationFernanda Cunha, Jessica Zuponcic, Francesco Rossi, et al.
Pageof 3